From: Novel bispecific aptamer targeting PD-1 and nucleolin for cancer immunotherapy
PD-1 aptamer | CGCACTATGTTTTACGAGCCGTTTCCTCGGCAGATAGTAAGTGCG |
AS1411 aptamer | GGTGGTGGTGGTTGTGGTGGTGGTGG |
S1 | AAAAAAAAAAAAAAAAAAAAAAAAA GGTGGTGGTGGTTGTGGTGGTGGTGG |
S2 | TTTTTTTTTTTTTTTTTTTTGGGGG CGCACTATGTTTTACGAGCCGTTTCCTCGGCAGATAGTAAGTGCGA |